TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $516,648 | -65.5% | 61,800 | +2.5% | 0.02% | -64.7% |
| Q2 2023 | $1,497,852 | +52.5% | 60,300 | -7.7% | 0.07% | +44.7% |
| Q1 2023 | $982,112 | +20.7% | 65,300 | -5.1% | 0.05% | +4.4% |
| Q4 2022 | $813,904 | +317.4% | 68,800 | +109.1% | 0.04% | +275.0% |
| Q3 2022 | $195,000 | +9.6% | 32,900 | -21.7% | 0.01% | +9.1% |
| Q2 2022 | $178,000 | +9.2% | 42,000 | +145.6% | 0.01% | +37.5% |
| Q1 2022 | $163,000 | -63.6% | 17,100 | -27.5% | 0.01% | -66.7% |
| Q4 2021 | $448,000 | -23.9% | 23,600 | +33.3% | 0.02% | -29.4% |
| Q3 2021 | $589,000 | +390.8% | 17,700 | +608.0% | 0.03% | +580.0% |
| Q1 2021 | $120,000 | +15.4% | 2,500 | +25.0% | 0.01% | 0.0% |
| Q4 2020 | $104,000 | +300.0% | 2,000 | +100.0% | 0.01% | +150.0% |
| Q3 2020 | $26,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |